• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动态灌注区域探测器CT在合并进行性纤维化间质性肺病的非小细胞肺癌中的应用

Dynamic perfusion area-detector CT in non-small cell lung cancer with progressive fibrosing interstitial lung disease.

作者信息

Ohno Yoshiharu, Fujisawa Yasuko, Yoshikawa Takeshi, Seki Shinichiro, Takenaka Daisuke, Fujii Kenji, Ito Yuya, Kimata Hirona, Akino Naruomi, Nagata Hiroyuki, Nomura Masahiko, Ueda Takahiro, Ozawa Yoshiyuki

机构信息

Department of Diagnostic Radiology, Fujita Health University School of Medicine, Toyoake, Japan.

Joint Research Laboratory of Advanced Medical Imaging, Fujita Health University School of Mediciine, Toyoake, Japan.

出版信息

Eur Radiol. 2025 May 22. doi: 10.1007/s00330-025-11653-7.

DOI:10.1007/s00330-025-11653-7
PMID:40402289
Abstract

OBJECTIVES

To determine the capability of dynamic contrast-enhanced (CE-) perfusion area-detector CT (ADCT) for detecting pathological structural changes in stage I non-small cell lung cancer (NSCLC) patients.

MATERIALS AND METHODS

Sixty-three consecutive stage I NSCLC patients with progressive fibrosing interstitial lung disease (PF-ILD) underwent dynamic CE-perfusion ADCT analyzed by dual-input maximum slope (DMS) methods for total, pulmonary arterial and systemic arterial perfusion (TP, PAP and SAP) maps, surgical treatment and pathological examination. Multicentric ROIs were then placed over sites assessed as normal lung, pulmonary emphysema, GGO or reticular pattern without traction bronchiectasis, reticular pattern with traction bronchiectasis and honeycombing in the resected lung. Next, an analysis of variance (ANOVA) followed by Tukey's honest significant difference (HSD) multiple comparison test was performed for a comparison of each of the perfusion parameters for five groups. Finally, discrimination accuracy for evaluation of lung parenchymal change was compared for all indexes and combined methods.

RESULTS

PAPs of abnormal lungs were significantly lower than that of normal lungs (p < 0.0001). SAPs of normal or emphysematous lungs were significantly lower than those of others (p < 0.0001). SAP of GGO or reticular pattern without traction bronchiectasis was significantly lower than that for reticular pattern with traction bronchiectasis and honeycombing (p < 0.0001). Discrimination accuracy of combined perfusion index was significantly higher than that of each index (p < 0.0001).

CONCLUSION

Dynamic CE-perfusion ADCT is useful for detecting pathological structural changes in stage I NSCLC patients with PF-ILD.

KEY POINTS

Question Can dynamic first-pass contrast-enhanced perfusion matrices evaluate parenchymal lung changes and disease severity of parenchymal diseases in stage I non-small cell lung cancer (NSCLC) patients? Findings Perfusion indexes differentiated significantly among normal lung, emphysema, GGO or reticular pattern without traction bronchiectasis, reticular pattern with traction bronchiectasis and honeycombing and significantly improved discrimination accuracy by combined methods. Clinical relevance Dynamic first-pass contrast-enhanced perfusion area-detector CT has the potential to assess underlying pathologies and pulmonary functional changes in stage I non-small cell carcinoma patients with progressive fibrosing interstitial lung disease.

摘要

目的

确定动态对比增强(CE)灌注面积探测器CT(ADCT)检测I期非小细胞肺癌(NSCLC)患者病理结构变化的能力。

材料与方法

63例连续的I期NSCLC合并进行性纤维化间质性肺疾病(PF-ILD)患者接受了动态CE灌注ADCT检查,采用双输入最大斜率(DMS)方法分析总灌注、肺动脉灌注和体动脉灌注(TP、PAP和SAP)图,并接受手术治疗和病理检查。然后在切除肺中评估为正常肺、肺气肿、磨玻璃影(GGO)或无牵拉支气管扩张的网状影、有牵拉支气管扩张的网状影和蜂窝状影的部位放置多中心感兴趣区(ROI)。接下来,进行方差分析(ANOVA),随后进行Tukey真实显著性差异(HSD)多重比较检验,以比较五组中每个灌注参数。最后,比较所有指标和联合方法评估肺实质变化的判别准确性。

结果

异常肺的PAP显著低于正常肺(p < 0.0001)。正常或肺气肿肺的SAP显著低于其他肺(p < 0.0001)。无牵拉支气管扩张的GGO或网状影的SAP显著低于有牵拉支气管扩张和蜂窝状影的网状影(p < 0.0001)。联合灌注指数的判别准确性显著高于每个指数(p < 0.0001)。

结论

动态CE灌注ADCT有助于检测I期NSCLC合并PF-ILD患者的病理结构变化。

关键点

问题 动态首过对比增强灌注矩阵能否评估I期非小细胞肺癌(NSCLC)患者的肺实质变化和实质疾病的严重程度? 发现 灌注指数在正常肺、肺气肿、无牵拉支气管扩张的GGO或网状影、有牵拉支气管扩张的网状影和蜂窝状影之间有显著差异,联合方法显著提高了判别准确性。 临床意义 动态首过对比增强灌注面积探测器CT有潜力评估I期非小细胞癌合并进行性纤维化间质性肺疾病患者的潜在病理和肺功能变化。

相似文献

1
Dynamic perfusion area-detector CT in non-small cell lung cancer with progressive fibrosing interstitial lung disease.动态灌注区域探测器CT在合并进行性纤维化间质性肺病的非小细胞肺癌中的应用
Eur Radiol. 2025 May 22. doi: 10.1007/s00330-025-11653-7.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer.正电子发射断层显像-计算机断层扫描用于评估疑似可切除非小细胞肺癌患者的纵隔淋巴结受累情况。
Cochrane Database Syst Rev. 2014 Nov 13;2014(11):CD009519. doi: 10.1002/14651858.CD009519.pub2.
4
CT features of pathologically proven smoking-related interstitial fibrosis: compared with emphysema and usual interstitial pneumonia.经病理证实的吸烟相关性间质性纤维化的CT特征:与肺气肿和普通间质性肺炎的比较
Eur Radiol. 2025 Sep;35(9):5626-5634. doi: 10.1007/s00330-025-11471-x. Epub 2025 Mar 6.
5
High-resolution deep learning reconstruction for coronary CTA: compared efficacy of stenosis evaluation with other methods at in vitro and in vivo studies.冠状动脉CTA的高分辨率深度学习重建:在体外和体内研究中与其他方法比较狭窄评估的疗效
Eur Radiol. 2025 Feb 4. doi: 10.1007/s00330-025-11376-9.
6
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
7
Dynamics of interstitial lung disease following immunosuppressive treatment differ between antisynthetase syndrome and systemic sclerosis.免疫抑制治疗后间质性肺疾病的动态变化在抗合成酶综合征和系统性硬化症之间存在差异。
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251336896. doi: 10.1177/17534666251336896. Epub 2025 May 8.
8
Integrating CT-Based Lung Fibrosis and MRI-Derived Right Ventricular Function for the Detection of Pulmonary Hypertension in Interstitial Lung Disease.整合基于CT的肺纤维化和MRI衍生的右心室功能以检测间质性肺疾病中的肺动脉高压
J Clin Med. 2025 Jul 28;14(15):5329. doi: 10.3390/jcm14155329.
9
Computed tomography scanning in the diagnosis of lower extremity phlebolymphedema.计算机断层扫描在下肢静脉性淋巴水肿诊断中的应用
J Vasc Surg Venous Lymphat Disord. 2025 May;13(3):102166. doi: 10.1016/j.jvsv.2024.102166. Epub 2025 Jan 3.
10
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.

本文引用的文献

1
Atezolizumab and nintedanib in patients with non-small cell lung cancer and interstitial lung disease.阿替利珠单抗与尼达尼布用于非小细胞肺癌合并间质性肺疾病患者的研究
J Thorac Dis. 2024 May 31;16(5):3371-3380. doi: 10.21037/jtd-24-45. Epub 2024 May 21.
2
Lung Magnetic Resonance Imaging: Technical Advancements and Clinical Applications.肺部磁共振成像:技术进展与临床应用
Invest Radiol. 2024 Jan 1;59(1):38-52. doi: 10.1097/RLI.0000000000001017. Epub 2023 Sep 14.
3
The vascular perspective on acute and chronic lung disease.从血管角度看急性和慢性肺病。
J Clin Invest. 2023 Aug 15;133(16):e170502. doi: 10.1172/JCI170502.
4
Pulmonary MRI with ultra-short TE using single- and dual-echo methods: comparison of capability for quantitative differentiation of non- or minimally invasive adenocarcinomas from other lung cancers with that of standard-dose thin-section CT.使用单/双回波方法的超短 TE 肺部 MRI:定量区分非浸润性腺癌或微浸润性腺癌与其他肺癌的能力与标准剂量薄层 CT 的比较。
Eur Radiol. 2024 Feb;34(2):1065-1076. doi: 10.1007/s00330-023-10105-4. Epub 2023 Aug 15.
5
Anti-Angiogenic Drugs Inhibit Interstitial Lung Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer.抗血管生成药物可抑制晚期非小细胞肺癌患者间质性肺疾病的进展。
Front Oncol. 2022 Jun 20;12:873709. doi: 10.3389/fonc.2022.873709. eCollection 2022.
6
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化(更新版)和成人进展性肺纤维化:美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2022 May 1;205(9):e18-e47. doi: 10.1164/rccm.202202-0399ST.
7
Vascular remodelling in idiopathic pulmonary fibrosis patients and its detrimental effect on lung physiology: potential role of endothelial-to-mesenchymal transition.特发性肺纤维化患者的血管重塑及其对肺生理的有害影响:内皮-间充质转化的潜在作用
ERJ Open Res. 2022 Mar 21;8(1). doi: 10.1183/23120541.00571-2021. eCollection 2022 Jan.
8
Dynamic contrast enhanced MRI for the evaluation of lung perfusion in idiopathic pulmonary fibrosis.动态对比增强 MRI 用于特发性肺纤维化肺灌注的评估。
Eur Respir J. 2022 Oct 13;60(4). doi: 10.1183/13993003.02058-2021. Print 2022 Oct.
9
State-of-the-art MR Imaging for Thoracic Diseases.胸部疾病的最新磁共振成像技术。
Magn Reson Med Sci. 2022 Mar 1;21(1):212-234. doi: 10.2463/mrms.rev.2020-0184. Epub 2021 Apr 29.
10
Pulmonary Functional Imaging: Part 2-State-of-the-Art Clinical Applications and Opportunities for Improved Patient Care.肺部功能成像:第 2 部分-最新临床应用和改善患者护理的机会。
Radiology. 2021 Jun;299(3):524-538. doi: 10.1148/radiol.2021204033. Epub 2021 Apr 13.